Market closed

IDEXX Laboratories/$IDXX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About IDEXX Laboratories

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Ticker

$IDXX
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
Westbrook, United States

Employees

11,000
Website
www.idexx.com

IDXX Metrics

BasicAdvanced
$35B
40.80
$10.36
1.33
-

$35B

1.33

$583.39

$398.50

565K

1.421

0.812

32.431

54.009

33.56%

22.79%

59.42%

40.8

9.099

21.43

21.43

44.138

7.16%

5.57%

7.04%

5.91%

What the Analysts think about IDXX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for IDEXX Laboratories stock.

IDXX Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IDXX Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

IDXX News

AllArticlesVideos
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

GlobeNewsWire·4 weeks ago
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

Business Wire·1 month ago
IDEXX Announces CFO Transition

IDEXX Announces CFO Transition

Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IDXX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IDEXX Laboratories stock?

IDEXX Laboratories (IDXX) has a market cap of $35B as of January 15, 2025.

What is the P/E ratio for IDEXX Laboratories stock?

The price to earnings (P/E) ratio for IDEXX Laboratories (IDXX) stock is 40.8 as of January 15, 2025.

Does IDEXX Laboratories stock pay dividends?

No, IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next IDEXX Laboratories dividend payment date?

IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders.

What is the beta indicator for IDEXX Laboratories?

IDEXX Laboratories (IDXX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.